Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
100.60    -2.60 (-2.52%)
Bid:
100.60
Ask:
102.00
Spread: 1.40 (1.392%)
Market Cap: £164.93m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Board Changes

18 Dec 2014 07:00

RNS Number : 1098A
Synthomer PLC
18 December 2014
 



18th December 2014

 

Synthomer plc

 

Board changes

 

Synthomer plc ('Synthomer' or 'the Company') is pleased to confirm that following its announcement on 18th November, Calum MacLean will formally succeed Adrian Whitfield as Group Chief Executive on 22nd January 2015.

 

Adrian Whitfield will also step down from the Board on the 22nd January and leave the Company after helping with a handover process.

The Company also announces that David Blackwood, Group Finance Director, has informed the Board that he wishes to retire following 7 successful years at Synthomer. David will remain as Group Finance Director, working closely with Calum MacLean until his successor is found.

 

The Board will initiate a comprehensive search for the next Group Finance Director and a further announcement will be made in due course.

 

Neil Johnson, Chairman, said:

 

"I am delighted to welcome Calum to the Board and look forward to working with him as he helps to take Synthomer into the next phase of its growth and development.

 

On behalf of everyone at Synthomer, I would like to thank David for his years of service. He has had a long and distinguished career in the chemicals industry and played a pivotal role helping to oversee the significant transformation of our business. We wish him all the best in his retirement."

 

- ENDS -

 

Enquiries:

 

Pendomer CommunicationsCharles Armitstead

 

+44 (0) 7703 330 269

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABRBDDSUBBGSR
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.